In natalizumab-associated PML, IFN-γ, TNF, IL-2 and IL-10 production is evident, and a transient increase in IL-10-producing cells after the initiation of natalizumab and high frequency in individuals with PML has been noted [90]. This evidence concerns the gene IL2 and progressive multifocal leukoencephalopathy.